Moreover, mutations in genes encoding either the GlyR alpha 2 subunit (Piton et al., 2011) or the aminomethyltransferase enzyme (AMT), which is an important factor involved in the degradation of glycine (Yu et al., 2013), have been found in patients affected by autism. This evidence concerns the gene AMT and autism.